LONDON, Nov. 3, 2020 /PRNewswire/ — Prescient, a biopharma product and portfolio strategy partner, announces the recent appointment of three new senior members: Gordon Gochenauer, Dr. Priya Kar and Dr. Cameron Mackenzie. They join the existing leadership team, which shapes the competitive strategies of Prescient’s clients through dynamic decision support.
Gordon joins Prescient with more than 15 years of dedicated oncology experience in market research and competitive intelligence. He has an MBA in market and strategy from Carnegie Mellon University and a BA in biochemistry from the University of Pennsylvania. Prior to joining Prescient, he led teams and projects at Kantar Health, AlphaImpactRx (now part of IQVIA) and Psyma International across the development timeline, including competitive intelligence, licensing and BD assessments, market landscapes, tracking studies, pricing and market access studies, and strategic workshops. At Prescient, Gordon is responsible for expanding our company’s presence in the Philadelphia and New Jersey areas and for supporting team professional development.
Priya joins Prescient with more than 15 years of healthcare experience, particularly in the realm of commercial and clinical insights and strategy development. She earned her PhD in molecular biology from the New Jersey Medical School and her MBA in pharmaceutical management and marketing from Rutgers Business School. Prior to joining Prescient, she served as a subject matter expert and trusted client advisor. Priya has co-authored several peer-reviewed scientific articles and industry-relevant white papers. At Prescient, Priya is responsible for driving growth within our Intelligence & Insight business, managing key business accounts and providing strategic leadership.
Cameron joins Prescient with 15 years of experience in the pharma and biotech industries. He spent his early career working in R&D and manufacturing at established companies before joining a start-up to lead the development, launch and global sales of a novel product. He holds a PhD in biophysical chemistry from the University of Glasgow, an MSc in chemistry from the University of Strathclyde and an MBA from Strathclyde Business School. At Prescient, Cameron is responsible for leading high-quality engagements with new and existing clients and applying his knowledge and experience to answer their strategic business questions.
“Clients partner with Prescient to understand the situation analysis, which impacts critical success factors underpinning their clinical and commercialization strategies, thus ensuring the product’s value proposition is differentiated and resonates with key market stakeholders,” says Dr. Rakesh Verma, Prescient’s President. “Gordon, Priya and Cameron bring extensive experience and deep-rooted expertise to support pharma cross-functional teams throughout the product life cycle in their decision making at critical inflection points.”
Biographies and contact information for the Prescient senior team can be found on www.PrescientHG.com.
About Prescient
At Prescient, science is at the core of everything we do. We are a biopharma product and portfolio strategy partner that specializes in turning the science of molecules into optimal patient outcomes and client value. Across therapeutic areas, we help develop winning strategies. When companies partner with us, a molecule in their hands has greater potential for success than the same science in the hands of their competitors.
Prescient has been a portfolio company of Baird Capital since 2017. For more information, please visit: www.PrescientHG.com.
Contact:
Christina Maffei
+1 908 342 3556
258162@email4pr.com
Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.
MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.
COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.
A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.